Factors Associated With Continuous Low-Dose Heparin Infusion for Central Venous Catheter Patency in Critically Ill Children Worldwide
- PMID: 27362853
- PMCID: PMC4980163
- DOI: 10.1097/PCC.0000000000000854
Factors Associated With Continuous Low-Dose Heparin Infusion for Central Venous Catheter Patency in Critically Ill Children Worldwide
Abstract
Objectives: To identify patient, hospital, and central venous catheter factors that may influence the use of low-dose heparin infusion for central venous catheter patency in critically ill children.
Design: Secondary analysis of an international multicenter observational study.
Setting: Fifty-nine PICUs over four study dates in 2012, involving seven countries.
Patients: Children less than 18 years old with a central venous catheter who were admitted to a participating unit and enrolled in the completed Prophylaxis against Thrombosis Practice study were included. All overflow patients were excluded.
Interventions: None.
Measurements and main results: Of the 2,484 patients in the Prophylaxis against Thrombosis Practice study, 1,312 patients had a central venous catheter. Five hundred seven of those patients used low-dose heparin infusion. The frequency of low-dose heparin infusion was compared across various patient, hospital, and central venous catheter factors using chi-square, Mann-Whitney U, and Fisher exact tests. In the multivariate analysis, age was not a significant factor for low-dose heparin infusion use. Patients with pulmonary hypertension had decreased low-dose heparin infusion use, whereas those with active surgical or trauma diagnoses had increased low-dose heparin infusion use. All centrally inserted central venous catheters were more likely to use low-dose heparin infusion when compared with peripherally inserted central venous catheters. The Asia-Pacific region showed increased low-dose heparin infusion use, along with community hospitals and smaller ICUs (< 10 beds).
Conclusions: Patient, central venous catheter, and hospital factors are associated with the use of low-dose heparin infusion in critically ill children. Further study is needed to evaluate the efficacy and persistence of low-dose heparin infusion use.
References
-
- Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. (8th Edition) 2008;133(6 Suppl):887S–968S. - PubMed
-
- Shah P, Shah V. Continuous Heparin Infusion to Prevent Thrombosis and Catheter Occlusion in Neonates with Peripherally Placed Percutaneous Central Venous Catheters. Cochrane Database Systematic Review. 2008;(2) Art. No. CD002772. - PubMed
-
- Shah P, Kalyn A, Satodia P, et al. A Randomized, Controlled Trial of Heparin Versus Placebo Infusion to Prolong the Usability of Peripherally Placed Percutaneous Central Venous Catheters (PCVCs) in Neonates. The HIP (Heparin Infusion for PCVC) Study American Academy of Pediatrics; 2007. pp. e284–e291. - PubMed
-
- Uslu S, Ozdemir H, Comert S, et al. The effect of Low-dose Heparin on Maintaining Peripherally Inserted Percutaneous Central Venous Catheters in Neonates. Journal of Perinatology. 2010;30:794–799. - PubMed
-
- Birch P, Ogden S, Hewson M. A Randomised,Controlled Trial of Heparin in Total Parenteral Nutrition to Prevent Sepsis Associated with Neonatal Long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. Arch Dis Child Fetal Neonatal Ed. 2010;95:F252–F257. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical